Ocular Infections and Treatments

SEP 9, 2026 · JOURNAL ARTICLE

Nanosuspension-based Ocular Therapeutics for Infection Control: Integrating Mucin Interactions and Tear Film Dynamics

Aaps Pharmscitech

This is a narrative review examining the potential applicability of nanosuspensions for ocular infection treatment; it raises questions about a delivery strategy rather than reporting empirical results or clinical evidence.

SEP 4, 2026 · JOURNAL ARTICLE

Disseminated Aspergillosis with Central Nervous System Involvement Among Patients with Hematologic Malignancies: A 30-Year Institutional Cohort of Clinical Features, Management, and Outcomes

Journal of Fungi

Small retrospective cohort (8 CNS cases) from a single institution over 30 years, identifying a rare phenotype with poor outcomes but explicitly cautioning that findings should be interpreted with caution due to small numbers and historical case clustering.

SEP 1, 2026 · JOURNAL ARTICLE

Clonal diversity and trend of methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA/MSSA) clinical isolates from pediatric patients in Myanmar: increased prevalence of clonal complex 1 (CC1) and ST121 MRSA

Ijid Regions

A single-centre, descriptive molecular epidemiology study of 175 isolates over 19 months documenting clone prevalence and resistance genes in pediatric S. aureus, without clinical outcomes or comparator groups.

SEP 1, 2026 · JOURNAL ARTICLE

Real-World Management and Patterns of Antibiotic Use in Patients with Keratitis and Ocular Surface Injuries: A Nationwide Survey Study in Spain

Antibiotics

A descriptive cross-sectional survey of practice patterns without a comparator, clinical outcome, or evidence of efficacy; documents real-world behaviour rather than testing an intervention or hypothesis.